Go Pro

Cencora (COR) Stock Forecast & Price Target

Cencora logo
$313.86 +3.85 (+1.24%)
Closing price 08/14/2026 03:59 PM Eastern
Extended Trading
$313.21 -0.64 (-0.20%)
As of 08/14/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Cencora - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
0
Hold
2
Buy
13

Based on 15 Wall Street analysts who have issued ratings for Cencora in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 15 analysts, 2 have given a hold rating, and 13 have given a buy rating for COR.

Consensus Price Target

$374.25
19.24% Upside
According to the 15 analysts' twelve-month price targets for Cencora, the average price target is $374.25. The highest price target for COR is $440.00, while the lowest price target for COR is $285.00. The average price target represents a forecasted upside of 19.24% from the current price of $313.86.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for COR and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Cencora and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

COR Analyst Ratings Over Time

TypeCurrent Forecast
8/15/25 to 8/15/26
1 Month Ago
7/16/25 to 7/16/26
3 Months Ago
5/17/25 to 5/17/26
1 Year Ago
8/15/24 to 8/15/25
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
13 Buy rating(s)
11 Buy rating(s)
12 Buy rating(s)
9 Buy rating(s)
Hold
2 Hold rating(s)
4 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$374.25$367.75$380.25$311.25
Forecasted Upside19.24% Upside19.48% Upside47.98% Upside6.13% Upside
Consensus RatingModerate BuyModerate BuyModerate BuyModerate Buy

COR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

COR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Cencora Stock vs. The Competition

TypeCencoraHealthcare CompaniesBroader Market
Consensus Rating Score
2.87
2.29
2.53
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside19.24% Upside785.24% Upside11.05% Upside
News Sentiment Rating
Positive News

See Recent COR News
Positive News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
8/11/2026
Stephen Baxter
Stephen Baxter
4 of 5 stars
Boost TargetOverweight$331.00 ➝ $395.00+21.85%
8/7/2026
Morgan Stanley logo
Morgan Stanley
4 of 5 stars
Erin Wright
Erin Wright
4 of 5 stars
Boost TargetOverweight$342.00 ➝ $346.00+7.00%
8/7/2026
Lisa Gill
Lisa Gill
4 of 5 stars
Boost TargetOverweight$382.00 ➝ $390.00+20.86%
8/6/2026 UpgradeHold (C+)Buy (B-)
8/6/2026Set Target$370.00+18.08%
8/6/2026Boost TargetBuy$412.00 ➝ $430.00+35.25%
8/6/2026 Reiterated RatingOutperform$350.00+10.18%
8/6/2026Reiterated RatingBuy
6/24/2026Boost TargetNeutral$280.00 ➝ $285.00-0.80%
6/10/2026Lower TargetOverweight$425.00 ➝ $350.00+25.38%
4/28/2026Initiated CoverageMarket Perform
3/17/2026 Reiterated RatingOutperform
1/22/2026UpgradeUnderperformBuy
11/10/2025Boost TargetBuy$350.00 ➝ $400.00+10.23%
11/6/2025Boost TargetOutperform$340.00 ➝ $380.00+7.70%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 01:57 PM ET.


Should I Buy Cencora Stock? COR Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, August 13, 2026. Please send any questions or comments about these Cencora pros and cons to contact@marketbeat.com.

Cencora
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Cencora, Inc.:

  • The company has demonstrated strong financial performance with a return on equity exceeding 125%, indicating effective management and profitability relative to shareholder equity.
  • Cencora, Inc. recently announced a quarterly dividend of $0.60, which translates to an annualized yield of approximately 0.7%. This consistent dividend payment can provide a steady income stream for investors.
  • Recent revenue growth of over 5% year-over-year showcases the company's ability to expand its market presence and increase sales, which is a positive indicator for future performance.
  • The current stock price is around $270, which may be perceived as attractive given the company's strong fundamentals and growth potential.
  • Cencora, Inc. has initiated a $2 billion stock buyback program, suggesting that the board believes the stock is undervalued, which can enhance shareholder value by reducing the number of shares outstanding.

Cencora
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Cencora, Inc. for these reasons:

  • The net margin is relatively low at around 0.79%, which may indicate challenges in controlling costs or pricing power in a competitive market.
  • Despite revenue growth, the company reported earnings per share of $4.00, which is lower than the previous year's $4.42, suggesting potential profitability concerns.
  • Analysts have mixed expectations for future earnings, with projections for the current fiscal year hovering around 17.84, which may not meet investor expectations for growth.
  • Insider ownership is only about 0.38%, which could raise concerns about alignment between management and shareholder interests.
  • Institutional ownership is high at 97.52%, which can lead to volatility if large investors decide to sell their stakes, impacting stock price stability.

COR Forecast - Frequently Asked Questions

According to the research reports of 15 Wall Street equities research analysts, the average twelve-month stock price forecast for Cencora is $374.25, with a high forecast of $440.00 and a low forecast of $285.00.

15 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cencora in the last twelve months. There are currently 2 hold ratings and 13 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" COR shares.

According to analysts, Cencora's stock has a predicted upside of 19.24% based on their 12-month stock forecasts.

Over the previous 90 days, Cencora's stock had 2 downgrades and 1 upgrade by analysts.

Cencora has been rated by research analysts at Bank of America, Barclays, Citigroup, Evercore, JPMorgan Chase & Co., Morgan Stanley, Robert W. Baird, UBS Group, Weiss Ratings, and Wells Fargo & Company in the past 90 days.

Analysts like Cencora more than other "healthcare" companies. The consensus rating for Cencora is Moderate Buy while the average consensus rating for "healthcare" companies is Hold. Learn more on how COR compares to other companies.


This page (NYSE:COR) was last updated on 8/15/2026 by MarketBeat.com Staff.
From Our Partners